Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05326776 · ClinicalTrials.gov registry record · Phase 2

Peripheral Oxytocin and Touch

A Phase 2 study, sponsored by University of California, San Diego.

Completed
Registry status
Phase 2
Development phase
20
Enrollment target

NCT05326776 is a Phase 2 study that has completed, run by University of California, San Diego. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05326776, a Phase 2 study, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
Phase 2
Development phase
20 participants
Enrollment target

Study Summary

Research shows that slow gentle skin stroking can activate special sensory nerves in the skin that elicit relaxing effects on the body and mind, similar to the effects of the hormone oxytocin. Studies also suggest that gentle stroking may even release oxytocin in the skin. However, we do not know what oxytocin does in the skin and how it affects nerves that send pleasant touch or pain signals to the brain. The proposed study will determine how individuals perceive gentle stroking and experimental pain before and after a skin injection of oxytocin compared to a placebo injection.

Interventions

  • DRUG Pitocin

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-04-05
Est. Completion 2023-08-03
Phase Phase 2

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT05326776

The ClinicalTrials.gov registry entry for NCT05326776 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pitocin is the first listed.

NCT05326776 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05326776 about?

NCT05326776 is a clinical study titled "Peripheral Oxytocin and Touch". Research shows that slow gentle skin stroking can activate special sensory nerves in the skin that elicit relaxing effects on the body and mind, similar to the effects of the hormone oxytocin. Studies also suggest that gentle stroking may even release oxytocin in the skin. However, we do not know wh...

What is the current status of trial NCT05326776?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2023-04-05. Estimated completion is 2023-08-03.

What interventions are being tested in trial NCT05326776?

The interventions under investigation include: Pitocin (DRUG).

Who is sponsoring clinical trial NCT05326776?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.